← Back to Clinical Trials
Recruiting NCT05266144

NCT05266144 Atrial Fibrillation Patients Treated With Catheter Ablation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05266144
Status Recruiting
Phase
Sponsor Peking Union Medical College Hospital
Condition Atrial Fibrillation
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2020-09-04
Primary Completion 2025-10-01

Trial Parameters

Condition Atrial Fibrillation
Sponsor Peking Union Medical College Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2020-09-04
Completion 2025-10-01
Interventions
radiofrequency ablation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a single-center prospective observational cohort study of atrial fibrillation patients treated with radiofrequency ablation.

Eligibility Criteria

Inclusion Criteria: * Non-valvular atrial fibrillation, including paroxysmal atrial fibrillation and persistent atrial fibrillation * 18-80 years old * The anteroposterior diameter of the left atrium is less than 50mm via TTE * Patient meets the intervention criteria for bilateral pulmonary vein isolation after evaluation by electrophysiological specialists * Patient consents to ablation treatment Exclusion Criteria: * Intra-atrial thrombus detected by TEE * Hyperthyroidism * Previous radiofrequency ablation for atrial fibrillation

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology